Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical TrialGlobe Newswire • 2 months agoWILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...